← back to search
L. Elit
McMaster University
· CA
Area of research
Obstetrics and Gynecology · Reproductive Medicine
Research interest
Research interests include Bevacizumab, Medicine, Ovarian cancer, Carboplatin, and Clinical endpoint.
h-index
—
citations
137
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial
The Lancet Oncology
2013
cited by
137
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Timothy Perren
· Novartis (Switzerland)
1
papers (2013–2013)
Galina Velikova
· University of Leeds
1
papers (2013–2013)
—
·
1
papers (2013–2013)
E Sabaté
· Gilead Sciences (United States)
1
papers (2013–2013)
Matthew Nankivell
· University of Padua
1
papers (2013–2013)
Martin R. Stockler
· The University of Sydney
1
papers (2013–2013)
Amit M. Oza
· University Health Network
1
papers (2013–2013)
Éric Pujade-Lauraine
· Hospital Universitario Ramón y Cajal
1
papers (2013–2013)
Ann Marie Swart
· London School of Hygiene & Tropical Medicine
1
papers (2013–2013)
Dan Stark
· University of Leeds
1
papers (2013–2013)
Andrés Cervantes
· Cervantes Institute
1
papers (2013–2013)
Wendi Qian
· Cambridge University Hospitals NHS Foundation Trust
1
papers (2013–2013)
Mark S. Carey
· BC Cancer Agency
1
papers (2013–2013)
—
·
1
papers (2013–2013)
Gunnar B. Kristensen
· Universitätsklinik für Frauenheilkunde und Geburtshilfe
1
papers (2013–2013)
Felix Hilpert
· University of Minnesota
1
papers (2013–2013)
Julia Brown
· University of Sheffield
1
papers (2013–2013)